News and innovations published by German exhibitorsback to overview
(No. 250) The company lifespin GmbH from BioPark Regensburg is a founding member of the Wyss Diagnostics Accelerator Program in the Industrial Participant Program at the renowned Harvard University in Cambridge in the USA. The program supports the development of breakthrough diagnostic technologies to improve disease screening management.
The company, founded in 2017 in the BioPark, is one of the so-called "deep data companies", i.e. an interdisciplinary team of today 17 employees combining diagnostic and bioanalytical methods with software solutions, including the use of artificial intelligence (AI). With the help of the most modern analyzes based on nuclear magnetic resonance technology, a database of metabolic profiles of more than 130,000 patients has already been built up, which already enables the analysis of more than a billion metabolic interactions.
The biotech company is expecting the first officially approved test for multiple sclerosis as early as next year. More tests for other neurological and cancer-related diseases are to follow.
Exhibitor: BioPark Regensburg GmbH